Economic impact of dementia in developing countries: An evaluation of costs of Alzheimer-type dementia in Argentina

International Psychogeriatrics

Volumn 19, Issue 4, 2007, Pages 705-718

  Allegri, Ricardo F ^a,b   Butman, Judith ^b   Arizaga, Raúl L ^b   Machnicki, Gerardo ^c   Serrano, Cecilia ^a,b   Taragano, Fernando E ^a,d   Sarasola, Diego ^a   Lon, Leandro ^a,b,d  

^a CEMIC   (Argentina)

^b Hospital General de Agudos Dr Abel Zubizarreta   (Argentina)

^c Novartis Argentina ^*  (Argentina)

^d Nuestra Sra de Las Nieves Nursing Home   (Argentina)

Author keywords

Alzheimer's disease; Caregiver; Dementia; Economic costs

Indexed keywords

AGED; ALZHEIMER DISEASE; ARGENTINA; ARTICLE; CAREGIVER; CAREGIVER BURDEN; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEMENTIA; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRY; OUTPATIENT CARE; STRUCTURED INTERVIEW;

AGED; ALZHEIMER DISEASE; ARGENTINA; CAREGIVERS; COST OF ILLNESS; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; DEMENTIA; DEVELOPING COUNTRIES; ECONOMICS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INSTITUTIONALIZATION; MALE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 34447134209     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610206003784     Document Type: Article

References (30)

1. Arizaga, R. L. (2002). Transcultural problems in clinical assessment. In T. Erkinjuntti and S. Gauthier (Eds.) Vascular Cognitive Impairment (pp. 523-538). London: Martin Dunitz.
2. Arizaga, R. L. (2005). Epidemiology of dementia. In C. A. Mangone, E. F. Allegri, R. L. Arizaga and J. A. Ollari (Eds.) Dementia: a Multidisciplinary Approach (pp. 7-17). Buenos Aires: Polemos.
3. Beeri, M. S., Werner, P., Adar, Z., Davidson, M. and Noy, S. (2002). Economic cost of Alzheimer disease in Israel. Alzheimer Disease and Associated Disorders, 16, 73-80.
4. Boada, M. et al. (1999). Coste de los recursos sanitarios de los pacientes en régimen ambulatorio diagnosticados de enfermedad de Alzheimer en España. [Costs of health care resources of ambulatory-case patients diagnosed with Alzheimer's disease in Spain]. Medicina Clínica, 113, 690-695.
5. Cavallo, M. C. and Fattore, G. (1997). The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Disease and Associated Disorders, 11, 184-190.
6. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thomson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314.
7. Ernst, R. L., Hay, J. W., Fenn, C., Tinklenberg, J. and Yesavage, J. A. (1997). Cognitive function and the costs of Alzheimer disease. An exploratory study. Archives of Neurology, 54, 687-693.
8. Ernst, R. L. and Hay, J. W. (1994) The US economic and social costs of Alzheimer's disease revisited. American Journal of Public Health, 84, 1261-1264.
9. Fenn, P. and Gray, A. (1999). Estimating long term savings from treatment of Alzheimer's disease: a modeling approach. Pharmacoeconomics, 16, 165-174.
10. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
11. Gilleard, C. J. (1987). Influence of emotional distress among supporters on the outcome of psychogeriatric day care. British Journal of Psychiatry, 150, 219-223.
12. Hauber, A. B., Grinasakthy, A., Snyde, E. H., Bala, M. V., Richter, A. and Mauskopf, J. A. (2000). Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. Pharmacoeconomics, 17, 351-360.
13. Hay, J. W. and Ernst, R. L. (1987). The economic costs of Alzheimer's disease. American Journal of Public Health, 77, 1169-1175.
14. Hu, T., Huang, L. and Cartwright, W. S. (1986). Evaluation of the costs of caring for the senile demented elderly: a pilot study. The Gerontologist, 26, 158-163.
15. Hughes, C. D., Berg, L., Danziger, L., Coben, L. A. and Martin, R. L. (1982). A new rating scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572.
16. Hux, M. J., O'Brien, B. J., Iskedjian, M., Goeree, R., Gagnon, M. and Gauthier, S. (1998). Relation between Alzheimer's disease and costs of caring. Canadian Medical Association Journal, 159, 457-465.
17. Ketzoian, C. et al. (1997). Prevalence of demential syndromes in a population of Uruguay. Study of "Villa del Cerro". Journal of the Neurological Sciences, 150, S155.
18. Kronborg Andersen, C., Sogaard, J., Hansen, E., Kragh-Sorensen, A., Hastrup, L. and Max, W. (1998). Cost of illness of dementia. In A. Wimo, B. Jönsson, G. Karlsson and B. Winblad (Eds.) Health Economics of Dementia (pp. 197-206). Chichester: John Wiley & Sons.
19. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
20. Menzin, J., Lang, K., Friedman, M., Neumann, P. and Cummings, J. L. (1999). The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995. American Journal of Geriatric Psychiatry, 7, 300-308.
21. Ostbye, T. and Crosse, E. (1994). Net economic costs of dementia in Canada. Canadian Medical Association Journal, 151, 1457-1464.
22. Prince, M., Acosta, D., Chiu, H., Scazufca, M., Varghese, M. and 10/66 Dementia Research Group (2003). Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet, 361, 909-917.
23. Quiroga, P., Klaassen, G. and Martinez, C. (2000). Dementia and cognitive impairment incidence in an urban Chilean population. Poster Presentation (unpublished). Joint meeting: Mental Health in the Elderly. International Psychogeriatric Association, Porto Alegre, Brazil.
24. Rice, D. P. et al. (1993). The economic burden of Alzheimer's disease care. Health Affairs, 12, 165-176.
25. Trabucchi, M. (1999). An economic perspective on Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 12, 29-38.
26. Wimo, A., Ljunggren, G. and Winblad, B. (1997). Costs of dementia and dementia care: a review. International Journal of Geriatric Psychiatry, 12, 841-856.
27. Wimo, A., Winblad, B., Aguero-Torrres, H. and von Strauss, E. (2003). The magnitude of dementia occurrence in the world. Alzheimer Disease and Associated Disorders, 17, 63-67.
28. Wimo, A. (2004). Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations. Drugs and Aging, 21, 279-295.
29. World Medical Association (2001). The WMA declaration of Helsinki 1960 with recommendations on biomedical on human subjects (modified in 1975, 1980, 1989, 1996 and 2000). Revista Neurologica Argentina, 26, 75-77.
30. Zarit, S. H., Orr, N. K. and Zarit, J. M. (1985). The Hidden Victims of Alzheimer's Disease: Families Under Stress. New York: New York University Press.